This report is available to subscribers of the Chilmark Advisory Service or may be purchased separately by clicking below. To accompany the release of this report, lead author Brian Murphy hosted a webinar presenting and discussing the report’s key findings — watch here.
As healthcare enterprises look to bounce back from the impact of the current pandemic, the need for alternatives to prevailing industry practice becomes apparent. The necessity of newer functionality in development and integration is now more pressing than ever before.
Application programming interfaces (APIs) have become an essential part of technology and its evolution, and decades of implementation have improved data access and integration significantly. However, conventional approaches have proven cumbersome and slow in the response to the current health crisis.
Currently, there is a vast amount of data scattered across various healthcare communities. Post-COVID-19, synergizing value from these various data sources will be a critical element in clinical and financial renewal. The report describes a general model for understanding the different categories of information exchange products and services, identifies sources of health-related data are most likely to be API-accessible, how APIs are contributing to development and integration across healthcare, and estimates the much larger potential of widespread adoption.
Additionally, the report includes detailed breakdowns of a key set of 20 influential vendors responsible for APIs that provide live healthcare data, usually for transactional purposes. Specifically, the focus is on the many uses of discrete data elements about single patients or members, as opposed to aggregated data about groups of patients or members. These breakdowns will be essential to building a greater understanding of the evolving, competitive market surrounding APIs and data integration.
Vendors Profiled: 1upHealth, 4Medica, Allscripts, Apple, athenahealth, Availity, Blue Button 2.0, Cerner, Change Healthcare, Datica, Epic, Human API, Meditech, NextGen, NCPDP, Particle Health, The Sequoia Project, Redox, Surescripts, and Validic